AlphaQuest LLC increased its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 969.6% in the 4th quarter ...

Its lead product candidate is LIVMARLI (maralixibat), an orally administered ... treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally.

After hours: March 14 at 4:23:31 p.m. EDT Loading Chart for MIRM ...